Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Oncology

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Back to index

Cancer Chemotherapy Regimen for Non-small Cell Lung Cancer


 CAMP
_________________________________________________________________
  cytoxan......... 300 mg/sqm IV on days 1 and 8.
  adriamycin...... 20 mg/sqm IV on days 1 and 8.
  methotrexate.... 15 mg/sqm IV on days 1 and 8.
  procarbazine.... 100 mg/day orally for 10 days.
  FREQUENCY....... Repeat cycle every 28 days.

  reference...
    Bitran JD.  Desser RK.  DeMeester TR.  Colman M.  Evans R. 
    Billings A.  Griem M.  Rubenstein L.  Shapiro C.  Golomb HM. 
    Cyclophosphamide, adriamycin, methotrexate, and procarbazine 
    (CAMP)--effective four-drug combination chemotherapy for 
    metastatic non-oat cell bronchogenic carcinoma. Cancer 
    Treatment Reports.  60(9):1225-30, 1976 Sep. 
  abstract...
    Twenty-three patients with metastatic non-oat cell 
    bronchogenic carcinoma (MNOBC) were treated with 
    cyclophosphamide, adriamycin, methotrexate, and procarbazine 
    (CAMP) after radiation therapy. Objective responses were seen 
    in 11 of 23 patients (48%) with a projected median survival 
    time of 12.5 months for responding patients and patients with 
    stable disease. Lung, liver, and cutaneous sites of 
    involvement proved to be highly responsive; bone involvement 
    was less responsive. CAMP is an effective combination in the 
    treatment of MNOBC and its use in patients with less advanced 
    disease should be explored. 
 

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


 

 advertisement.gif (61x7 -- 0 bytes)

 

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.